Northeast Financial Consultants’s Invesco Pharmaceuticals ETF PJP Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q4 | – | Sell |
-3,135
| Closed | -$243K | – | 366 |
|
2021
Q3 | $243K | Sell |
3,135
-494
| -14% | -$38.3K | 0.02% | 306 |
|
2021
Q2 | $292K | Sell |
3,629
-4,420
| -55% | -$356K | 0.02% | 288 |
|
2021
Q1 | $635K | Buy |
8,049
+7
| +0.1% | +$552 | 0.05% | 179 |
|
2020
Q4 | $574K | Sell |
8,042
-775
| -9% | -$55.3K | 0.05% | 183 |
|
2020
Q3 | $563K | Sell |
8,817
-4
| -0% | -$255 | 0.05% | 164 |
|
2020
Q2 | $571K | Buy |
+8,821
| New | +$571K | 0.05% | 157 |
|
2018
Q1 | – | Sell |
-3,300
| Closed | -$211K | – | 155 |
|
2017
Q4 | $211K | Sell |
3,300
-325
| -9% | -$20.8K | 0.07% | 139 |
|
2017
Q3 | $237K | Sell |
3,625
-5,650
| -61% | -$369K | 0.09% | 132 |
|
2017
Q2 | $582K | Sell |
9,275
-3,150
| -25% | -$198K | 0.23% | 81 |
|
2017
Q1 | $730K | Sell |
12,425
-17,550
| -59% | -$1.03M | 0.3% | 61 |
|
2016
Q4 | $1.68M | Sell |
29,975
-60,340
| -67% | -$3.38M | 0.75% | 25 |
|
2016
Q3 | $5.56M | Sell |
90,315
-50,105
| -36% | -$3.08M | 2.35% | 7 |
|
2016
Q2 | $8.91M | Sell |
140,420
-4,554
| -3% | -$289K | 3.96% | 3 |
|
2016
Q1 | $8.71M | Sell |
144,974
-4,959
| -3% | -$298K | 4.57% | 2 |
|
2015
Q4 | $10.5M | Buy |
149,933
+4,729
| +3% | +$331K | 5.44% | 2 |
|
2015
Q3 | $9.63M | Buy |
145,204
+20,655
| +17% | +$1.37M | 4.89% | 2 |
|
2015
Q2 | $9.76M | Buy |
124,549
+10,361
| +9% | +$812K | 4.37% | 2 |
|
2015
Q1 | $8.72M | Buy |
114,188
+49,361
| +76% | +$3.77M | 3.97% | 3 |
|
2014
Q4 | $4.31M | Buy |
64,827
+12,852
| +25% | +$855K | 2.27% | 9 |
|
2014
Q3 | $3.31M | Buy |
51,975
+5,863
| +13% | +$373K | 1.82% | 12 |
|
2014
Q2 | $2.82M | Buy |
46,112
+8,625
| +23% | +$527K | 1.59% | 13 |
|
2014
Q1 | $2.12M | Buy |
37,487
+23,285
| +164% | +$1.32M | 1.25% | 17 |
|
2013
Q4 | $760K | Buy |
+14,202
| New | +$760K | 0.51% | 38 |
|